OM
Opaleye Management Portfolio holdings
AUM
$758M
1-Year Est. Return
77.57%
This Fund
S&P 500
1 Year Est. Return
+77.57%
AUM
$707M
AUM Growth
+$213M
(+43%)
Holding
52
Top Buys
| 1 | +$13.9M | |
| 2 | +$12.7M | |
| 3 | +$6.46M | |
| 4 |
Journey Medical
DERM
|
+$6.35M |
| 5 |
Treace Medical Concepts
TMCI
|
+$4.59M |
Top Sells
| 1 | +$7.95M | |
| 2 | +$6.23M | |
| 3 | +$5.63M | |
| 4 |
Arvinas
ARVN
|
+$5.25M |
| 5 |
EPIX
ESSA Pharma
EPIX
|
+$3.76M |
Sector Composition
| 1 | Healthcare | 99.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Harrow
HROW
$2.01B
| $188M | 26.6% |
3,905,000
|
|
||
2
Eton Pharmaceutcials
ETON
$456M
| $62.1M | 8.79% |
2,860,000
|
|
||
3
Liquidia Corp
LQDA
$2.7B
| $59.5M | 8.41% |
2,615,000
+140,000
|
|
||
4
Rhythm Pharmaceuticals
RYTM
$6.19B
| $46.6M | 6.59% |
461,700
-13,300
|
|
||
5
Immunome
IMNM
$2.41B
| $37.3M | 5.27% |
3,185,000
-344,581
|
|
||
|
SNWV
6
SANUWAVE Health Inc
SNWV
$209M
| $36.7M | 5.19% |
980,000
|
|
||
7
Codexis
CDXS
$91.2M
| $31.2M | 4.41% |
12,795,000
+195,000
|
|
||
8
TG Therapeutics
TGTX
$4.78B
| $19.3M | 2.73% |
535,000
|
|
||
9
Ocular Therapeutix
OCUL
$1.95B
| $18.6M | 2.64% |
1,595,000
|
|
||
10
CG Oncology
CGON
$4.86B
| $16.5M | 2.33% |
410,000
+144,000
|
|
||
11
Stoke Therapeutics
STOK
$2.08B
| $16M | 2.27% |
682,017
+119,897
|
|
||
12
Apogee Therapeutics
APGE
$4.78B
| $14.4M | 2.04% |
+363,257
|
|
||
13
Alkermes
ALKS
$4.97B
| $13.5M | 1.91% |
+450,000
|
|
||
14
Disc Medicine
IRON
$2.51B
| $12.8M | 1.81% |
193,773
+7,355
|
|
||
15
Sarepta Therapeutics
SRPT
$1.76B
| $11.3M | 1.59% |
585,000
+85,000
|
|
||
16
Larimar Therapeutics
LRMR
$441M
| $10.6M | 1.49% |
3,720,867
-389,133
|
|
||
17
Xoma
XOMA
$316M
| $9.83M | 1.39% |
255,087
|
|
||
18
Rezolute
RZLT
$307M
| $8.49M | 1.2% |
903,442
|
|
||
|
19
Arvinas
ARVN
$852M
| $8.42M | 1.19% |
987,818
-692,182
|
|
||
20
Edgewise Therapeutics
EWTX
$3.22B
| $8.11M | 1.15% |
500,000
+10,000
|
|
||
21
Annexon
ANNX
$835M
| $7.93M | 1.12% |
+2,600,000
|
|
||
22
Gossamer Bio
GOSS
$98.3M
| $7.17M | 1.01% |
2,725,000
-820,000
|
|
||
23
Protagonist Therapeutics
PTGX
$5.76B
| $6.98M | 0.99% |
105,000
|
|
||
|
24
Journey Medical
DERM
$272M
| $6.91M | 0.98% |
971,064
+876,064
|
|
||
25
Sol-Gel Technologies
SLGL
$255M
| $5.97M | 0.84% |
+204,835
|
|